OSTENIL® MINI is indicated to relieve pain and improve mobility in degenerative and traumatic changes of small synovial joints, such as osteoarthritis.
The aim of the injection is to increase the concentration of hyaluronic acid in the joint, which often decreases as a result of osteoarthritis. The structure of the hyaluronic acid contained in OSTENIL®, OSTENIL® PLUS and OSTENIL® MINI matches human hyaluronic acid.
OSTENIL® MINI: pre-filled syringe to relieve pain induced by osteoarthritis. Effective, safe and well-tolerated.
Inject OSTENIL® MINI into the affected joint once a week for a total of 1–3 injections. Several joints may be treated at the same time. Depending on the severity of the joint disease the beneficial effects of a treatment cycle may last at least six months. Repeat treatment cycles may be administered as required. In case of joint effusion, the effusion should be reduced first. The contents and outer surface of the OSTENIL® MINI pre-filled syringe are sterile as long as the sterile pack is intact. Take the pre-filled syringe out of the sterile pack, unscrew the Luer lock cap from the syringe, attach a suitable needle (for example 18 to 25 G) and secure it by turning slightly. Remove any air bubble, if present, before injection.